| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |